CGON
Price
$38.00
Change
-$0.13 (-0.34%)
Updated
Oct 7 closing price
Capitalization
2.91B
41 days until earnings call
DNTH
Price
$34.70
Change
+$0.24 (+0.70%)
Updated
Oct 7 closing price
Capitalization
1.37B
Interact to see
Advertisement

CGON vs DNTH

Header iconCGON vs DNTH Comparison
Open Charts CGON vs DNTHBanner chart's image
CG Oncology
Price$38.00
Change-$0.13 (-0.34%)
Volume$735.98K
Capitalization2.91B
Dianthus Therapeutics
Price$34.70
Change+$0.24 (+0.70%)
Volume$326.07K
Capitalization1.37B
CGON vs DNTH Comparison Chart in %
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. DNTH commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a StrongBuy and DNTH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (CGON: $38.00 vs. DNTH: $34.70)
Brand notoriety: CGON and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 82% vs. DNTH: 44%
Market capitalization -- CGON: $2.91B vs. DNTH: $1.37B
CGON [@Biotechnology] is valued at $2.91B. DNTH’s [@Biotechnology] market capitalization is $1.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileDNTH’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • DNTH’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 3 TA indicator(s) are bullish while DNTH’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 3 bullish, 5 bearish.
  • DNTH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -5.66% price change this week, while DNTH (@Biotechnology) price change was -11.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

Reported Earning Dates

CGON is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.91B) has a higher market cap than DNTH($1.37B). DNTH YTD gains are higher at: 59.174 vs. CGON (32.497). DNTH has higher annual earnings (EBITDA): -129.49M vs. CGON (-157.09M). CGON has more cash in the bank: 661M vs. DNTH (257M). CGON has less debt than DNTH: CGON (994K) vs DNTH (1.33M). DNTH has higher revenues than CGON: DNTH (4.85M) vs CGON (551K).
CGONDNTHCGON / DNTH
Capitalization2.91B1.37B212%
EBITDA-157.09M-129.49M121%
Gain YTD32.49759.17455%
P/E RatioN/A3.24-
Revenue551K4.85M11%
Total Cash661M257M257%
Total Debt994K1.33M75%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
29
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONDNTH
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LEVOX12.64N/A
N/A
Lazard US Equity Concentrated Open
ITHCX43.56N/A
N/A
Invesco Technology C
GCEUX103.66N/A
N/A
Green Century Equity Institutional
FMDRX33.85N/A
N/A
Franklin Mutual Global Discovery R6
SRUAX15.48N/A
N/A
Meeder Spectrum Adviser

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with NUVL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-0.34%
NUVL - CGON
60%
Loosely correlated
-0.56%
SYRE - CGON
58%
Loosely correlated
-3.90%
IDYA - CGON
58%
Loosely correlated
-2.07%
XNCR - CGON
56%
Loosely correlated
+2.04%
ACLX - CGON
56%
Loosely correlated
+0.98%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with XNCR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+0.70%
XNCR - DNTH
47%
Loosely correlated
+2.04%
SYRE - DNTH
45%
Loosely correlated
-3.90%
OCUL - DNTH
44%
Loosely correlated
+5.01%
VRDN - DNTH
44%
Loosely correlated
+0.82%
CGON - DNTH
43%
Loosely correlated
-0.34%
More